Table of Pharmacogenomic Biomarkers

  Abacavir Infectious Diseases HLA-B Boxed Warning, Dosage and Administration, Contraindications, Warnings and Precautions   Abemaciclib (1) Oncology ESR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Studies   Abemaciclib (2) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies   Abemaciclib (3) Oncology MKI67 Clinical Studies   Abrocitinib Dermatology CYP2C19 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Adagrasib Oncology KRAS Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies   Ado-Trastuzumab Emtansine Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies   Aducanumab-avwa Neurology APOE Boxed Warning, Warnings and Precautions, Clinical Studies, Patient Counseling Information   Afatinib Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Alectinib Oncology ALK Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies   Alglucosidase Alfa Inborn Errors of Metabolism GAA Warnings and Precautions   Allopurinol Oncology HLA-B Warnings   Alpelisib (1)  Oncology ERBB2
(HER2) Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Alpelisib (2) Oncology ESR
(Hormone Receptor) Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Alpelisib (3) Oncology PIK3CA Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Amifampridine Phosphate Neurology NAT2 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Amikacin Infectious Diseases     MT-RNR1     Warnings and Precautions   Amitriptyline Psychiatry CYP2D6 Precautions   Amivantamab-vmjw Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Amoxapine Psychiatry CYP2D6 Precautions   Amphetamine Psychiatry CYP2D6 Clinical Pharmacology   Anakinra Rheumatology NLRP3 Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Anastrozole Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Drug Interactions, Clinical Studies   Anifrolumab-fnia Rheumatology Gene Signature
(IFN) Clinical Pharmacology, Clinical Studies   Arformoterol (1) Pulmonary UGT1A1 Clinical Pharmacology   Arformoterol (2) Pulmonary CYP2D6 Clinical Pharmacology   Aripiprazole Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Aripiprazole Lauroxil Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Arsenic Trioxide Oncology PML-RARA Indications and Usage, Clinical Studies   Articaine and Epinephrine (1) Anesthesiology G6PD Warnings and Precautions   Articaine and Epinephrine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings and Precautions   Asciminib Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Ascorbic Acid Endocrinology G6PD Dosage and Administration, Warnings and Precautions, Adverse Reactions, Patient Counseling Information   Atezolizumab (1) Oncology CD274
(PD-L1) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies   Atezolizumab (2)   Oncology Gene Signature
(T-effector) Clinical Studies   Atezolizumab (3) Oncology EGFR Indications and Usage, Adverse Reactions, Clinical Studies   Atezolizumab (4) Oncology ALK Indications and Usage, Adverse Reactions, Clinical Studies   Atezolizumab (5) Oncology BRAF Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Atomoxetine Psychiatry CYP2D6 Dosage and Administration, Warnings and Precautions, Adverse Reactions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology   Ascorbic Acid, PEG-3350, Potassium Chloride, Sodium Ascorbate, Sodium Chloride, and Sodium Sulfate Gastroenterology G6PD Warnings and Precautions, Adverse Reactions   Avapritinib (1) Oncology PDGFRA Indications and Usage, Dosage and Administration, Clinical Studies   Avapritinib (2) Oncology KIT Clinical Studies   Avatrombopag (1) Hematology F2
(Prothrombin) Warnings and Precautions   Avatrombopag (2) Hematology F5
(Factor V Leiden) Warnings and Precautions   Avatrombopag (3) Hematology PROC Warnings and Precautions   Avatrombopag (4) Hematology PROS1 Warnings and Precautions   Avatrombopag (5) Hematology SERPINC1
(Antithrombin III) Warnings and Precautions   Avatrombopag (6) Hematology CYP2C9 Clinical Pharmacology   Avelumab Oncology CD274
(PD-L1) Clinical Studies   Azacitidine (1) Oncology CBL Clinical Studies   Azacitidine (2) Oncology PTPN11 Clinical Studies   Azacitidine (3) Oncology RAS Clinical Studies   Azathioprine (1) Rheumatology TPMT Dosage and Administration,  Warnings, Precautions, Drug Interactions, Adverse Reactions, Clinical Pharmacology   Azathioprine (2) Rheumatology NUDT15 Dosage and Administration, Warnings, Precautions, Adverse Reactions, Clinical Pharmacology   Belinostat Oncology UGT1A1 Dosage and Administration, Clinical Pharmacology   Belzutifan (1) Oncology CYP2C19 Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology   Belzutifan (2) Oncology UGT2B17 Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology   Belzutifan (3) Oncology VHL Clinical Studies   Bempedoic Acid and Ezetimibe Endocrinology Nonspecific
(Heterozygous Familial Hypercholesterolemia) Indications and Usage, Adverse Reactions, Clinical Studies   Betaine Inborn Errors of Metabolism CBS, MMADHC, MTHFR (Homocystinuria Deficiency) Indications and Usage, Warnings and Precautions, Clinical Pharmacology, Clinical Studies   Binimetinib (1) Oncology BRAF Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies    Binimetinib (2) Oncology UGT1A1 Indications and Usage, Use in Specific Populations   Blinatumomab (1) Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Blinatumomab (2) Oncology CD19 Indications and Usage, Use in Specific Populations   Boceprevir Infectious Diseases IFNL3
(IL28B) Clinical Pharmacology   Bosutinib Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies   Brentuximab Vedotin (1) Oncology ALK Use in Specific Populations, Clinical Studies   Brentuximab Vedotin (2) Oncology TNFRSF8
(CD30) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Brexpiprazole Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Brigatinib Oncology ALK Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Brivaracetam Neurology CYP2C19 Clinical Pharmacology   Bupivacaine (1) Anesthesiology G6PD Warnings   Bupivacaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings   Bupropion Psychiatry CYP2D6 Clinical Pharmacology   Bupropion and Dextromethorphan  Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Busulfan Oncology BCR-ABL1
(Philadelphia chromosome) Clinical Studies   Cabotegravir and Rilpivirine (1) Infectious Diseases HLA-B Clinical Studies   Cabotegravir and Rilpivirine (2) Infectious Diseases UGT1A1 Clinical Pharmacology   Cabozantinib Oncology RET Clinical Studies   Capmatinib Oncology MET Indications and Usage, Dosage and Administration, Clinical Studies   Capecitabine (1) Oncology DPYD Warnings and Precautions, Clinical Pharmacology, Patient Counseling Information   Capecitabine (2) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Capivasertib (1) Oncology AKT1 Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Capivasertib (2) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Clinical Studies   Capivasertib (3) Oncology ESR
(Hormone Receptor) Indications and Usage, Dosage and Administration, Clinical Studies   Capivasertib (4) Oncology PIK3CA Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Capivasertib (5) Oncology PTEN Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Carbamazepine (1) Neurology HLA-B Boxed Warning, Warnings, Precautions   Carbamazepine (2) Neurology HLA-A Warnings   Carglumic Acid Inborn Errors of Metabolism NAGS Indications and Usage, Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Cariprazine Psychiatry CYP2D6 Clinical Pharmacology   Carisoprodol Rheumatology CYP2C19 Use in Specific Populations, Clinical Pharmacology   Carvedilol Cardiology CYP2D6 Drug Interactions, Clinical Pharmacology   Casimersen Neurology DMD Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Ceftriaxone (1) Infectious Diseases G6PD Warnings   Ceftriaxone (2) Infectious Diseases Nonspecific
(Congenital Methemoglobinemia) Warnings   Celecoxib Rheumatology CYP2C9 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Cemiplimab-rwlc (1) Oncology ALK Indications and Usage, Clinical Studies   Cemiplimab-rwlc (2) Oncology CD274
(PD-L1) Indications and Usage, Dosage and Administration, Clinical Studies   Cemiplimab-rwlc (3) Oncology EGFR Indications and Usage, Clinical Studies   Cemiplimab-rwlc (4) Oncology ROS1 Indications and Usage, Clinical Studies   Ceritinib Oncology ALK Indications and Usage, Dosage and Administration, Warning and Precautions, Adverse Reactions, Clinical Studies   Cerliponase Alfa Inborn Errors of Metabolism TPP1 Indications and Usage, Use in Specific Populations, Clinical Studies   Cetuximab (1) Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Cetuximab (2) Oncology RAS Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies   Cetuximab (3) Oncology BRAF Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Cevimeline Dental CYP2D6 Precautions   Chloroprocaine (1) Anesthesiology G6PD Warnings   Chloroprocaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings   Chloroquine Infectious Diseases G6PD Precautions, Adverse Reactions   Chlorpropamide Endocrinology G6PD Precautions   Cholic Acid Inborn Errors of Metabolism AMACR, AKR1D1, CYP7A1, CYP27A1, DHCR7, HSD3B2
(Bile Acid Synthesis Disorders) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies   Cisplatin Oncology TPMT Adverse Reactions   Citalopram (1) Psychiatry CYP2C19 Dosage and Administration, Warnings, Clinical Pharmacology   Citalopram (2) Psychiatry CYP2D6 Clinical Pharmacology   Clobazam Neurology CYP2C19 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Clomipramine Psychiatry CYP2D6 Precautions   Clopidogrel Cardiology CYP2C19 Boxed Warning, Warnings and Precautions, Clinical Pharmacology   Clozapine Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Cobimetinib Oncology BRAF Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Codeine Anesthesiology CYP2D6 Boxed Warning, Warnings and Precautions, Use in Specific Populations, Patient Counseling Information   Crizanlizumab-tmca Hematology HBB Adverse Reactions, Clinical Studies   Crizotinib (1) Oncology ALK Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Crizotinib (2) Oncology ROS1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Dabrafenib (1) Oncology BRAF Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Dabrafenib (2) Oncology G6PD Warnings and Precautions, Adverse Reactions, Patient Counseling Information   Dabrafenib (3) Oncology RAS Dosage and Administration, Warnings and Precautions   Daclatasvir Infectious Diseases IFNL3
(IL28B) Clinical Studies   Dacomitinib Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Dapsone (1) Dermatology G6PD Warnings and Precautions, Use in Specific Populations, Patient Counseling Information   Dapsone (2) Dermatology Nonspecific
(Congenital Methemoglobinemia) Warnings and Precautions, Adverse Reactions, Patient Counseling Information   Dapsone (3) Infectious Diseases G6PD Precautions, Adverse Reactions, Overdosage   Darifenacin Urology CYP2D6 Clinical Pharmacology   Dasabuvir, Ombitasvir, Paritaprevir, and Ritonavir Infectious Diseases IFNL3
(IL28B) Clinical Studies   Dasatinib Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies   Denileukin Diftitox Oncology IL2RA
(CD25 antigen) Indications and Usage, Clinical Studies   Desipramine Psychiatry CYP2D6 Precautions   Desflurane Anesthesiology CACNA1S, RYR1 
(Genetic Susceptibility to Malignant Hyperthermia) Contraindications, Warnings and Precautions, Clinical Pharmacology   Desmopressin  Hematology F8 Indications and Usage, Dosage and Administration, Clinical Pharmacology   Desvenlafaxine Psychiatry CYP2D6 Clinical Pharmacology   Deutetrabenazine Neurology CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Dexlansoprazole Gastroenterology CYP2C19 Drug Interactions, Clinical Pharmacology   Dextromethorphan and Quinidine Neurology CYP2D6 Warnings and Precautions, Clinical Pharmacology   Diazepam Neurology CYP2C19 Clinical Pharmacology   Dinutuximab Oncology MYCN Clinical Studies   Docetaxel Oncology ESR, PGR
(Hormone Receptor) Clinical Studies   Dolutegravir Infectious Diseases UGT1A1 Clinical Pharmacology   Donepezil Neurology CYP2D6 Clinical Pharmacology   Dostarlimab-gxly Oncology Microsatellite Instability, Mismatch Repair Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Doxepin (1) Psychiatry CYP2D6 Clinical Pharmacology   Doxepin (2) Psychiatry CYP2C19 Clinical Pharmacology   Dronabinol Gastroenterology CYP2C9 Use in Specific Populations, Clinical Pharmacology   Drospirenone and Ethinyl Estradiol Gynecology CYP2C19 Clinical Pharmacology   Duloxetine Psychiatry CYP2D6 Drug Interactions   Durvalumab (1) Oncology     ALK Indications and Usage, Clinical Studies   Durvalumab (2) Oncology  EGFR Indications and Usage, Clinical Studies   Durvalumab (3) Oncology CD274
(PD-L1) Clinical Pharmacology, Clinical Studies   Durvalumab (4) Oncology Mismatch Repair Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Duvelisib Oncology Chromosome 17p Clinical Studies   Eculizumab (1) Neurology ACHR Indications and Usage, Clinical Studies   Eculizumab (2) Neurology AQP4 Indications and Usage, Clinical Studies   Efavirenz Infectious Diseases CYP2B6 Clinical Pharmacology   Efgartigimod Alfa-fcab Neurology ACHR Indications and Usage, Clinical Pharmacology, Clinical Studies   Eflornithine Oncology MYCN Adverse Reactions, Clinical Studies   Elacestrant (1) Oncology     ESR
(Hormone Receptor) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Elacestrant (2) Oncology     ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Elagolix Gynecology SLCO1B1 Clinical Pharmacology   Elbasvir and Grazoprevir Infectious Diseases IFNL3
(IL28B) Clinical Studies   Elexacaftor, Ivacaftor, and Tezacaftor Pulmonary CFTR Indications and Usage, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Eliglustat Inborn Errors of Metabolism CYP2D6 Indications and Usage, Dosage and Administration, Contraindications, Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Elranatamab-bcmm (1) Oncology Chromosome 17p Clinical Studies   Elranatamab-bcmm (2) Oncology Chromosome 4p;14q Clinical Studies   Elranatamab-bcmm (3) Oncology Chromosome 14q;16q Clinical Studies   Elosulfase Inborn Errors of Metabolism GALNS Indications and Usage, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Eltrombopag (1) Hematology F5
(Factor V Leiden) Warnings and Precautions   Eltrombopag (2) Hematology SERPINC1
(Antithrombin III) Warnings and Precautions   Eltrombopag (3) Hematology Chromosome 7 Adverse Reactions   Eltrombopag (4) Hematology Chromosome 13 Adverse Reactions   Emapalumab-lzsg Hematology PRF1, RAB27A, SH2D1A, STXBP2, STX11, UNC13D, XIAP (Hemophagocytic Lymphohistiocytosis) Clinical Studies   Enasidenib Oncology IDH2 Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies   Encorafenib (1) Oncology BRAF Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies, Patient Counseling Information   Encorafenib (2) Oncology RAS Dosage and Administration, Warnings and Precautions, Clinical Studies     Entrectinib (1) Oncology ROS1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Entrectinib (2) Oncology NTRK Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Eplontersen Neurology TTR Adverse Reactions, Clinical Pharmacology, Clinical Studies   Erdafitinib (1) Oncology FGFR3 Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies, Patient Counseling Information   Erdafitinib (2)  Oncology CYP2C9 Use in Specific Populations, Clinical Pharmacology   Eribulin (1) Oncology ERBB2
(HER2) Clinical Studies   Eribulin (2) Oncology ESR, PGR
(Hormone Receptor) Clinical Studies   Erlotinib Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Erythromycin and Sulfisoxazole Infectious Diseases G6PD Precautions   Escitalopram (1) Psychiatry CYP2D6 Drug Interactions   Escitalopram (2) Psychiatry CYP2C19 Adverse Reactions   Esomeprazole Gastroenterology CYP2C19 Drug Interactions, Clinical Pharmacology   Estradiol and Progesterone (1) Gynecology PROC Contraindications   Estradiol and Progesterone (2) Gynecology PROS1 Contraindications   Estradiol and Progesterone (3) Gynecology

SERPINC1
(Antithrombin III)

Contraindications   Estradiol Valerate Gynecology ESR, PGR
(Hormone Receptor) Warnings   Eteplirsen Neurology DMD Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies   Etrasimod Gastroenterology CYP2C9 Drug Interactions, Use in Specific Populations, Clinical Pharmacology   Everolimus (1) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Everolimus (2) Oncology ESR
(Hormone Receptor) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Evinacumab-dgnb (1) Endocrinology LDLR Clinical Studies   Evinacumab-dgnb (2) Endocrinology     Nonspecific
(Homozygous Familial Hypercholesterolemia) Indication and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Evolocumab (1) Endocrinology Nonspecific
(Heterozygous Familial Hypercholesterolemia) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Evolocumab (2) Endocrinology Nonspecific
(Homozygous Familial Hypercholesterolemia) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Exemestane Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Dosage and Administration, Clinical Studies   Fam-Trastuzumab Deruxtecan-nxki (1) Oncology

ERBB2
(HER2)

Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies

  Fam-Trastuzumab Deruxtecan-nxki (2) Oncology ESR
(Hormone Receptor) Clinical Studies   Fesoterodine Urology CYP2D6 Drug Interactions, Clinical Pharmacology   Fosphenytoin (1) Neurology CYP2C9 Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology   Fosphenytoin (2)  Neurology HLA-B Warnings and Precautions   Flibanserin (1) Gynecology CYP2C9 Clinical Pharmacology   Flibanserin (2) Gynecology CYP2C19 Adverse Reactions, Use in Specific Populations, Clinical Pharmacology   Flibanserin (3) Gynecology CYP2D6 Clinical Pharmacology   Fluorouracil (1) Dermatology DPYD Contraindications, Warnings   Fluorouracil (2) Oncology DPYD Warnings and Precautions, Clinical Pharmacology, Patient Counseling Information   Fluoxetine Psychiatry CYP2D6 Warnings and Precautions, Drug Interactions, Clinical Pharmacology   Flurbiprofen Rheumatology CYP2C9 Clinical Pharmacology   Flutamide Oncology G6PD Warnings   Fluvoxamine Psychiatry CYP2D6 Drug Interactions   Formoterol (1) Pulmonary CYP2D6 Clinical Pharmacology   Formoterol (2) Pulmonary CYP2C19 Clinical Pharmacology   Fosdenopterin Neurology MOCS1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Fruquintinib Oncology RAS Indications and Usage, Clinical Studies   Fulvestrant (1) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies   Fulvestrant (2) Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Pharmacology, Clinical Studies   Futibatinib Oncology FGFR2 Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Galantamine Neurology CYP2D6 Clinical Pharmacology   Ganaxolone Neurology CDKL5 Indications and Usage, Clinical Studies   Gefitinib (1) Oncology EGFR Indications and Usage, Dosage and Administration, Clinical Studies   Gefitinib (2) Oncology CYP2D6 Clinical Pharmacology   Gemtuzumab Ozogamicin Onoclogy CD33 Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Gentamicin Infectious Diseases     MT-RNR1     Warnings   Gilteritinib Oncology FLT3 Indications and Usage, Dosage and Administration, Clinical Studies   Givosiran Gastroenterology CPOX, HMBS, PPOX
(Acute Hepatic Porphyria) Clinical Studies   Glimepiride Endocrinology G6PD Warnings and Precautions, Adverse Reactions   Glipizide Endocrinology G6PD Precautions   Glyburide Endocrinology G6PD Precautions   Glycerol Phenylbutyrate (1) Inborn Errors of Metabolism ASS1, CPS1, OTC
(Urea Cycle Disorders) Indications and Usage, Adverse Reactions, Clinical Studies   Glycerol Phenylbutyrate (2) Inborn Errors of Metabolism NAGS Indications and Usage   Golodirsen Neurology DMD Indications and Usage, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Goserelin Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Clinical Studies   Hydralazine Cardiology Nonspecific
(NAT) Clinical Pharmacology   Hydroxychloroquine Infectious Diseases G6PD Warnings and Precautions, Adverse Reactions   Ibrutinib (1) Oncology Chromosome 17p Indications and Usage, Clinical Studies   Ibrutinib (2) Oncology Chromosome 11q Clinical Studies   Ibrutinib (3) Oncology MYD88 Clinical Studies   Iloperidone Psychiatry CYP2D6 Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology   Imatinib (1) Oncology KIT Indications and Usage, Dosage and Administration, Clinical Studies   Imatinib (2) Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Imatinib (3) Oncology PDGFRB Indications and Usage, Dosage and Administration, Clinical Studies   Imatinib (4) Oncology FIP1L1-PDGFRA Indications and Usage, Dosage and Administration, Clinical Studies   Imipramine Psychiatry CYP2D6 Precautions   Inclisiran Endocrinology   Nonspecific
(Heterozygous Familial Hypercholesterolemia) Indications and Usage, Clinical Studies   Indacaterol Pulmonary UGT1A1 Clinical Pharmacology   Inebilizumab-cdon Neurology AQP4 Indications and Usage, Clinical Studies   Inotersen Neurology TTR Adverse Reactions, Clinical Pharmacology   Inotuzumab Ozogamicin Oncology BCR-ABL1
(Philadelphia chromosome) Clinical Studies   Ipilimumab (1) Oncology HLA-A Clinical Studies   Ipilimumab (2) Oncology Microsatellite Instability, Mismatch Repair Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies   Ipilimumab (3) Oncology CD274
(PD-L1) Indications and Usage, Dosage and Administration, Use in Specific Populations, Clinical Studies   Ipilimumab (4) Oncology ALK Indications and Usage, Adverse Reactions, Clinical Studies   Ipilimumab (5) Oncology EGFR Indications and Usage, Adverse Reactions, Clinical Studies   Irinotecan Oncology UGT1A1 Dosage and Administration, Clinical Pharmacology, Clinical Studies   Isatuximab- irfc (1) Oncology Chromosome 17p Clinical Studies   Isatuximab- irfc (2) Oncology Chromosome 4p;14q Clinical Studies   Isatuximab- irfc (3) Oncology Chromosome 14q;16q Clinical Studies   Isoflurane Anesthesiology CACNA1S, RYR1 
(Genetic Susceptibility to Malignant Hyperthermia) Contraindications, Warnings, Clinical Pharmacology   Isoniazid, Pyrazinamide, and Rifampin Infectious Diseases Nonspecific
(NAT) Clinical Pharmacology   Isosorbide Dinitrate Cardiology CYB5R Overdosage   Isosorbide Mononitrate Cardiology CYB5R Overdosage   Ivacaftor Pulmonary CFTR Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Ivacaftor and Lumacaftor Pulmonary CFTR Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies   Ivacaftor and Tezacaftor Pulmonary CFTR Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Ivosidenib Oncology IDH1 Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies   Ixabepilone (1) Oncology ERBB2
(HER2) Clinical Studies   Ixabepilone (2) Oncology ESR, PGR
(Hormone Receptor) Clinical Studies   Lacosamide Neurology CYP2C19 Clinical Pharmacology   Lansoprazole Gastroenterology CYP2C19 Drug Interactions, Clinical Pharmacology   Lapatinib (1) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Lapatinib (2) Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Lapatinib (3) Oncology HLA-DQA1 Clinical Pharmacology   Lapatinib (4) Oncology HLA-DRB1 Clinical Pharmacology   Larotrectinib Oncology NTRK Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Lecanemab-irmb Neurology     APOE Boxed Warning, Warnings and Precautions, Clinical Studies, Patient Counseling Information   Ledipasvir and Sofosbuvir Infectious Diseases IFNL3
(IL28B) Clinical Studies   Lenalidomide Hematology Chromosome 5q Boxed Warning, Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies   Leniolisib (1) Pulmonary     PIK3CD Clinical Studies   Leniolisib (2) Pulmonary     PIK3R1 Clinical Studies   Lenvatinib Oncology Microsatellite Instability, Mismatch Repair Indications and Usage, Adverse Reactions, Clinical Studies   Lesinurad Rheumatology CYP2C9 Drug Interactions, Clinical Pharmacology   Letrozole Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Studies   Levothyroxine Endocrinology Nonspecific (Congenital Hypothyroidism) Indications and Usage, Warnings and Precautions, Use in Specific Populations   Lidocaine and Prilocaine (1) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings and Precautions   Lidocaine and Prilocaine (2) Anesthesiology G6PD Warnings and Precautions, Clinical Pharmacology   Lidocaine and Tetracaine (1) Anesthesiology G6PD Warnings and Precautions   Lidocaine and Tetracaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings and Precautions   Lofexidine Anesthesiology CYP2D6 Use in Specific Populations   Lomitapide Endocrinology Nonspecific
(Homozygous Familial Hypercholesterolemia) Indications and Usage, Warnings and Precautions, Adverse Reactions, Clinical Studies   Lonafarnib (1) Inborn Errors of Metabolism LMNA Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies   Lonafarnib (2) Inborn Errors of Metabolism ZMPSTE24 Indications and Usage, Use in Specific Populations   Lorlatinib (1) Oncology ALK Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Lorlatinib (2) Oncology ROS1 Adverse Reactions   Lumasiran Urology AGXT Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Luspatercept–aamt Hematology HBB Clinical Studies   Lusutrombopag (1) Hematology F2
(Prothrombin) Warnings and Precautions   Lusutrombopag (2) Hematology F5
(Factor V Leiden) Warnings and Precautions   Lusutrombopag (3) Hematology PROC Warnings and Precautions   Lusutrombopag (4) Hematology PROS1 Warnings and Precautions   Lusutrombopag (5) Hematology SERPINC1
(Antithrombin III) Warnings and Precautions   Lutetium Lu 177 Dotatate Oncology SSTR  Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Lutetium Lu 177 Vipivotide Tetraxetan Oncology FOLH1
(PSMA) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Mafenide Infectious Diseases G6PD Warnings, Adverse Reactions   Maralixibat (1) Gastroenterology JAG1 Clinical Studies   Maralixibat (2) Gastroenterology ABCB4 Clinical Pharmacology, Clinical Studies   Maralixibat (3) Gastroenterology ABCB11 Indications and Usage, Clinical Pharmacology, Clinical Studies   Maralixibat (4) Gastroenterology ATP8B1 Clinical Pharmacology, Clinical Studies   Maralixibat (5) Gastroenterology MYO5B Clinical Pharmacology, Clinical Studies   Maralixibat (6) Gastroenterology TJP2 Clinical Pharmacology, Clinical Studies   Margetuximab-cmkb (1) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Pharmacology, Clinical Studies   Margetuximab-cmkb (2) Oncology FCGR2A
(CD32A) Clinical Pharmacology   Margetuximab-cmkb (3) Oncology FCGR2B
(CD32B) Clinical Pharmacology   Margetuximab-cmkb (4) Oncology FCGR3A
(CD16A) Clinical Pharmacology   Mavacamten Cardiology CYP2C19 Dosage and Administration, Clinical Pharmacology   Mavorixafor Hematology CXCR4 Clinical Studies   Mecasermin Endocrinology Nonspecific 
(GH) Indications and Usage, Clinical Studies   Meclizine Neurology CYP2D6 Warnings and Precautions   Medroxyprogesterone Gynecology ESR
(Hormone Receptor) Warnings   Meloxicam Anesthesiology CYP2C9 Use in Specific Populations, Clinical Pharmacology   Mepivacaine (1) Anesthesiology G6PD Warnings   Mepivacaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings   Mepolizumab Oncology     FIP1L1-PDGFRA     Adverse Reactions, Clinical Studies   Mercaptopurine (1) Oncology TPMT Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology   Mercaptopurine (2) Oncology NUDT15 Dosage and Administration, Warnings and Precautions, Clinical Pharmacology   Methylene Blue Hematology G6PD Contraindications, Warnings and Precautions   Metoclopramide (1) Gastroenterology CYB5R Use in Specific Populations   Metoclopramide (2) Gastroenterology G6PD Use in Specific Populations, Overdosage   Metoclopramide (3) Gastroenterology CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Metoprolol Cardiology CYP2D6 Clinical Pharmacology   Metreleptin Endocrinology LEP Contraindications   Midostaurin (1) Oncology FLT3 Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Midostaurin (2) Oncology NPM1 Clinical Studies   Midostaurin (3) Oncology KIT Clinical Studies   Migalastat Inborn Errors of Metabolism GLA Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies   Mirabegron Urology CYP2D6 Clinical Pharmacology   Mirvetuximab Soravtansine-gynx Oncology FOLR1 Indications and Usage, Dosage and Administration, Clinical Studies   Mitapivat Hematology PKLR Clinical Studies   Mivacurium Anesthesiology BCHE Warnings, Precautions, Clinical Pharmacology   Mobocertinib Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Modafinil Psychiatry CYP2D6 Clinical Pharmacology   Mycophenolic Acid Transplantation HPRT1 Warnings and Precautions   Nalidixic Acid Infectious Diseases G6PD Precautions, Adverse Reactions   Nateglinide Endocrinology CYP2C9 Drug Interactions   Nebivolol Cardiology CYP2D6 Dosage and Administration, Clinical Pharmacology   Nedosiran Nephrology AGXT Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Nefazodone Psychiatry CYP2D6 Precautions   Neomycin Infectious Diseases   MT-RNR1     Warnings   Neratinib (1) Oncology ERBB2
(HER2)

Indications and Usage, Adverse Reactions, Clinical Studies

  Neratinib (2) Oncology ESR, PGR
(Hormone Receptor)

Clinical Studies

  Nilotinib (1) Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Nilotinib (2) Oncology UGT1A1 Clinical Pharmacology   Niraparib Oncology BRCA (Homologous Recombination Deficiency) Indications and Usage, Dosage and Administration, Clinical Studies   Nitrofurantoin Infectious Diseases G6PD Warnings, Adverse Reactions   Nirogacestat (1) Oncology APC Clinical Studies   Nirogacestat (2) Oncology CTNNB1 Clinical Studies   Nivolumab (1) Oncology BRAF Adverse Reactions, Clinical Studies   Nivolumab (2) Oncology CD274
(PD-L1) Indications and Usage, Dosage and Administration, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Nivolumab (3) Oncology Microsatellite Instability, Mismatch Repair Indications and Usage, Clinical Studies   Nivolumab (4) Oncology EGFR Indications and Usage, Adverse Reactions, Clinical Studies   Nivolumab (5) Oncology ALK Indications and Usage, Adverse Reactions, Clinical Studies   Nivolumab (6) Oncology ERBB2
(HER2) Adverse Reactions, Clinical Studies   Nivolumab and Relatlimab-rmbw (1) Oncology BRAF Clinical Studies   Nivolumab and Relatlimab-rmbw (2) Oncology CD274
(PD-L1) Clinical Studies   Nivolumab and Relatlimab-rmbw (3) Oncology LAG3 Clinical Studies   Nortriptyline Psychiatry CYP2D6 Precautions   Nusinersen Neurology SMN2 Clinical Pharmacology, Clinical Studies   Obinutuzumab Oncology MS4A1
(CD20 antigen) Clinical Studies   Odevixibat (1) Gastroenterology ABCB11 Indications and Usage, Clinical Pharmacology, Clinical Studies   Odevixibat (2)
  Gastroenterology    ATP8B1     Indications and Usage, Clinical Pharmacology, Clinical Studies   Odevixibat (3) Gastroenterology     JAG1     Clinical Studies   Odevixibat (4) Gastroenterology     NOTCH2     Clinical Studies   Olaparib (1) Oncology BRCA Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies   Olaparib (2) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Olaparib (3) Oncology ESR, PGR
(Hormone Receptor)

Indications and Usage, Clinical Studies

  Olaparib (4) Oncology BRCA, Genomic Instability (Homologous Recombination Deficiency) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Olaparib (5) Oncology Homologous Recombination Repair Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Olaparib (6) Oncology PPP2R2A Clinical Studies   Olaratumab Oncology PDGFRA Clinical Studies   Oliceridine Anesthesiology CYP2D6 Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology   Olutasidenib Oncology IDH1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Omacetaxine Oncology BCR-ABL1
(Philadelphia chromosome) Clinical Studies   Ombitasvir, Paritaprevir, and Ritonavir Infectious Diseases IFNL3
(IL28B) Clinical Studies   Omeprazole Gastroenterology CYP2C19 Drug Interactions, Clinical Pharmacology   Oxymetazoline and Tetracaine (1) Anesthesiology G6PD Warnings and Precautions   Oxymetazoline and Tetracaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings and Precautions   Ondansetron Gastroenterology CYP2D6 Clinical Pharmacology   Osimertinib Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Ospemifene (1) Gynecology CYP2C9 Clinical Pharmacology   Ospemifene (2) Gynecology CYP2B6 Clinical Pharmacology   Oxcarbazepine Neurology HLA-B Warnings and Precautions   Palbociclib (1) Oncology ESR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Studies   Palbociclib (2) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies   Paliperidone Psychiatry CYP2D6 Clinical Pharmacology   Palonosetron Gastroenterology CYP2D6 Clinical Pharmacology   Panitumumab (1) Oncology EGFR Adverse Reactions, Clinical Pharmacology, Clinical Studies   Panitumumab (2) Oncology RAS Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies   Pantoprazole Gastroenterology CYP2C19 Clinical Pharmacology   Parathyroid Hormone Inborn Errors of Metabolism CASR Indications and Usage, Clinical Studies   Paroxetine Psychiatry CYP2D6 Drug Interactions, Clinical Pharmacology   Patisiran Neurology TTR Adverse Reactions, Clinical Pharmacology, Clinical Studies   Pazopanib (1) Oncology UGT1A1 Clinical Pharmacology   Pazopanib (2) Oncology HLA-B Clinical Pharmacology   Peginterferon Alfa-2b Infectious Diseases IFNL3
(IL28B) Clinical Pharmacology   Pegloticase Rheumatology G6PD Boxed Warning, Contraindications, Warnings and Precautions, Adverse Reactions, Patient Counseling Information   Pembrolizumab (1) Oncology BRAF Adverse Reactions, Clinical Studies   Pembrolizumab (2) Oncology CD274
(PD-L1) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Pembrolizumab (3) Oncology Microsatellite Instability, Mismatch Repair Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies     Pembrolizumab (4) Oncology EGFR Indications and Usage, Adverse Reactions, Clinical Studies   Pembrolizumab (5) Oncology ALK Indications and Usage, Adverse Reactions, Clinical Studies   Pembrolizumab (6) Oncology Tumor Mutational Burden Indications and Usage, Dosage and Administration, Use in Specific Populations, Clinical Studies   Pembrolizumab (7) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies   Pemetrexed (1) Oncology ALK Indications and Usage, Adverse Reactions, Clinical Studies   Pemetrexed (2) Oncology EGFR Indications and Usage, Adverse Reactions, Clinical Studies   Pemetrexed (3) Oncology CD274
(PD-L1) Clinical Studies   Pemigatinib (1) Oncology FGFR1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Pemigatinib (2) Oncology FGFR2 Indications and Usage, Dosage and Administration, Clinical Studies   Perphenazine Psychiatry CYP2D6 Precautions, Clinical Pharmacology   Pertuzumab (1) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies   Pertuzumab (2) Oncology ESR, PGR
(Hormone Receptor) Clinical Studies   Phenytoin (1) Neurology CYP2C9 Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology   Phenytoin (2) Neurology CYP2C19 Clinical Pharmacology   Phenytoin (3) Neurology HLA-B Warnings and Precautions   Pimozide Psychiatry CYP2D6 Dosage and Administration, Precautions   Piroxicam Rheumatology CYP2C9 Clinical Pharmacology   Pirtobrutinib (1) Oncology BTK Clinical Studies   Pirtobrutinib (2) Oncology Chromosome 11q Clinical Studies   Pirtobrutinib (3) Oncology Chromosome 17p Clinical Studies   Pirtobrutinib (4) Oncology IGHV Clinical Studies   Pirtobrutinib (5) Oncology TP53 Clinical Studies   Pitavastatin Endocrinology Nonspecific
(Heterozygous Familial Hypercholesterolemia)

Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies

  Pitolisant Psychiatry CYP2D6 Dosage and Administration, Use in Specific Populations, Clinical Pharmacology   Plazomicin Infectious Diseases     MT-RNR1   Warnings and Precautions   Polatuzumab Vedotin-piiq (1) Oncology   BCL2     Clinical Studies   Polatuzumab Vedotin-piiq (2) Oncology     BCL6     Clinical Studies   Polatuzumab Vedotin-piiq (3) Oncology     MYC     Clinical Studies   Ponatinib Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies   Pralsetinib Oncology CCDC6-RET, KIF5B-RET,  RET Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Prasugrel (1) Cardiology CYP2C19 Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Prasugrel (2) Cardiology CYP2C9 Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Prasugrel (3) Cardiology CYP3A5 Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Prasugrel (4) Cardiology CYP2B6 Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Primaquine (1) Infectious Diseases G6PD Contraindications, Warnings, Precautions, Adverse Reactions, Overdosage   Primaquine (2)  Infectious Diseases CYB5R Precautions, Adverse Reactions   Probenecid Rheumatology G6PD Adverse Reactions   Procainamide Cardiology Nonspecific
(NAT) Adverse Reactions, Clinical Pharmacology   Propafenone Cardiology CYP2D6 Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology   Propranolol Cardiology CYP2D6 Clinical Pharmacology   Protriptyline Psychiatry CYP2D6 Precautions   Quinidine Cardiology CYP2D6 Precautions   Quinine Sulfate (1) Infectious Diseases G6PD Warnings and Precautions   Quinine Sulfate (2) Infectious Diseases CYP2D6 Clinical Pharmacology   Quizartinib Oncology FLT3 Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Studies   Rabeprazole Gastroenterology CYP2C19 Drug Interactions, Clinical Pharmacology   Raloxifene Oncology ESR
(Hormone Receptor) Clinical Studies   Raltegravir Infectious Diseases UGT1A1 Clinical Pharmacology   Ramucirumab (1) Oncology EGFR Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Ramucirumab (2) Oncology RAS Clinical Studies   Rasburicase (1) Oncology G6PD Boxed Warning, Contraindications, Warnings and Precautions   Rasburicase (2) Oncology CYB5R Boxed Warning, Contraindications, Warnings and Precautions   Ravulizumab-cwvz (1)  Neurology ACHR Indications and Usage, Clinical Studies   Ravulizumab-cwvz (2) Neurology AQP4 Indications and Usage, Clinical Studies   Regorafenib Oncology RAS Indications and Usage, Clinical Studies   Repotrectinib (1) Oncology ROS1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Repotrectinib (2) Oncology NTRK Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Resmetirom Gastroenterology ABCG2 Clinical Pharmacology   Ribociclib (1) Oncology ESR, PGR (Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Studies   Ribociclib (2) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies   Rimegepant Neurology CYP2C9 Clinical Pharmacology   Risdiplam Neurology SMN1, SMN2 Clinical Studies   Risperidone Psychiatry CYP2D6 Clinical Pharmacology   Rituximab Oncology MS4A1
(CD20 antigen) Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Rivaroxaban Cardiology F5
(Factor V Leiden) Clinical Studies   Ropeginterferon Alfa-2b-njft Hematology JAK2 Clinical Pharmacology, Clinical Studies   Ropivacaine (1) Anesthesiology G6PD Warnings   Ropivacaine (2) Anesthesiology Nonspecific
(Congenital Methemoglobinemia) Warnings   Rosuvastatin Endocrinology SLCO1B1 Clinical Pharmacology   Rozanolixizumab-noli (1) Neurology     ACHR Indications and Usage, Clinical Pharmacology, Clinical Studies   Rozanolixizumab-noli (2) Neurology     MUSK     Indications and Usage, Clinical Pharmacology, Clinical Studies   Rucaparib (1) Oncology BRCA Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Rucaparib (2) Oncology CYP2D6 Clinical Pharmacology   Rucaparib (3) Oncology CYP1A2 Clinical Pharmacology   Rucaparib (4) Oncology BRCA, Loss of Heterozygosity (Homologous Recombination Deficiency) Warnings and Precautions, Adverse Reactions, Clinical Studies   Sacituzumab Govitecan-hziy (1) Oncology UGT1A1 Warnings and Precautions, Clinical Pharmacology   Sacituzumab Govitecan-hziy (2) Oncology     BRCA     Clinical Studies   Sacituzumab Govitecan-hziy (3) Oncology     ESR
(Hormone Receptor)    Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies   Sacituzumab Govitecan-hziy (4) Oncology     ERBB2
(HER2)     Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Studies   Sacrosidase Inborn Errors of Metabolism Nonspecific
(Congenital Sucrase-Isomaltase Deficiency) Indications and Usage, Adverse Reactions, Clinical Pharmacology   Satralizumab-mwge Neurology AQP4 Indications and Usage, Adverse Reactions, Clinical Studies   Selpercatinib Oncology RET Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Setmelanotide (1) Endocrinology LEPR Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Setmelanotide (2) Endocrinology PCSK1 Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Setmelanotide (3) Endocrinology POMC Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Sevoflurane Anesthesiology CACNA1S, RYR1 
(Genetic Susceptibility to Malignant Hyperthermia) Contraindications, Warnings, Clinical Pharmacology   Simeprevir Infectious Diseases IFNL3
(IL28B) Clinical Pharmacology, Clinical Studies   Siponimod Neurology CYP2C9 Dosage and Administration, Contraindications, Drug Interactions, Use in Specific Populations, Clinical Pharmacology   Sodium Nitrite (1) Toxicology G6PD Warnings and Precautions   Sodium Nitrite (2) Toxicology Nonspecific
(Congenital Methemoglobinemia) Boxed Warning, Warnings and Precautions   Sodium Oxybate Neurology ALDH5A1
(Succinic Semialdehyde Dehydrogenase Deficiency) Contraindications   Sodium Phenylbutyrate Inborn Errors of Metabolism ASS1, CPS1, OTC
(Urea Cycle Disorders) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology   Sofosbuvir Infectious Diseases IFNL3
(IL28B) Clinical Studies   Sofosbuvir and Velpatasvir Infectious Diseases IFNL3
(IL28B) Clinical Studies   Sofosbuvir, Velpatasvir, and Voxilaprevir Infectious Diseases IFNL3
(IL28B) Clinical Studies   Sotorasib Oncology KRAS Indication and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies   Streptomycin Infectious Diseases     MT-RNR1     Warnings   Succimer Hematology G6PD Clinical Pharmacology   Succinylcholine (1) Anesthesiology BCHE Warnings, Precautions   Succinylcholine (2) Anesthesiology

CACNA1S, RYR1 
(Genetic Susceptibility to Malignant Hyperthermia)

Boxed Warning, Contraindications, Warnings, Precautions, Adverse Reactions, Clinical Pharmacology   Sulfadiazine Infectious Diseases G6PD Warnings   Sulfamethoxazole and Trimethoprim (1) Infectious Diseases G6PD Precautions   Sulfamethoxazole and Trimethoprim (2) Infectious Diseases Nonspecific
(NAT) Precautions   Sulfasalazine (1) Gastroenterology G6PD Precautions   Sulfasalazine (2) Gastroenterology Nonspecific
(NAT) Clinical Pharmacology   Synthetic Conjugated Estrogens, A (1) Gynecology PROC Contraindications   Synthetic Conjugated Estrogens, A (2) Gynecology PROS1 Contraindications   Synthetic Conjugated Estrogens, A (3) Gynecology SERPINC1
(Antithrombin III) Contraindications   Tafamidis Cardiology TTR Clinical Pharmacology, Clinical Studies   Tafenoquine Infectious Diseases G6PD Dosage and Administration, Contraindications, Warnings and Precautions, Use in Specific Populations, Patient Counseling Information   Talazoparib (1) Oncology BRCA Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Talazoparib (2) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies   Talazoparib (3) Oncology    
  Homologous Recombination Repair     Indications and Usage, Dosage and Administrations, Adverse Reactions, Drug Interactions, Clinical Studies   Tamoxifen (1) Oncology ESR, PGR
(Hormone Receptor) Indications and Usage, Adverse Reactions, Clinical Pharmacology, Clinical Studies   Tamoxifen (2) Oncology F5
(Factor V Leiden) Warnings and Precautions   Tamoxifen (3) Oncology F2
(Prothrombin) Warnings and Precautions   Tamoxifen (4) Oncology CYP2D6 Clinical Pharmacology   Tamsulosin Urology CYP2D6 Warnings and Precautions, Adverse Interactions, Clinical Pharmacology   Tebentafusp-tebn Oncology HLA-A Indications and Usage, Dosage and Administration, Clinical Studies   Teclistamab-cqyv (1) Oncology Chromosome 17p Clinical Studies    Teclistamab-cqyv (2) Oncology Chromosome 4p;14q Clinical Studies    Teclistamab-cqyv (3) Oncology Chromosome 14q;16q Clinical Studies    Telaprevir Infectious Diseases IFNL3
(IL28B) Clinical Pharmacology, Clinical Studies   Tepotinib (1) Oncology ALK Clinical Studies   Tepotinib (2) Oncology EGFR Clinical Studies   Tepotinib (3) Oncology MET Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Studies   Tetrabenazine Neurology CYP2D6 Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology   Thioguanine (1) Oncology TPMT Dosage and Administration, Warnings, Precautions, Clinical Pharmacology   Thioguanine (2) Oncology NUDT15 Dosage and Administration, Warnings, Precautions, Clinical Pharmacology   Thioridazine  Psychiatry CYP2D6 Contraindications, Warnings, Precautions   Ticagrelor Cardiology CYP2C19 Clinical Pharmacology   Tipiracil and Trifluridine (1) Oncology ERBB2
(HER2) Indications and Usage, Adverse Reactions, Clinical Studies   Tipiracil and Trifluridine (2) Oncology RAS Indications and Usage, Clinical Studies   Tislelizumab-jsgr Oncology CD274
(PD-L1) Clinical Studies   Tobramycin Infectious Diseases     MT-RNR1     Warnings and Precautions   Tofersen Oncology     SOD1 Indications and Usage, Use in Specific Populations, Clinical Studies   Tolazamide Endocrinology G6PD Precautions   Tolbutamide Endocrinology G6PD Precautions   Tolterodine Urology CYP2D6 Warnings and Precautions, Drug Interactions, Clinical Pharmacology   Toremifene Oncology ESR
(Hormone Receptor) Indications and Usage, Clinical Studies   Tovorafenib Oncology BRAF Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Studies   Tramadol Anesthesiology CYP2D6 Boxed Warning, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology, Patient Counseling Information   Trametinib (1) Oncology BRAF Indications and Usage, Dosage and Administration, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Trametinib (2) Oncology G6PD Adverse Reactions   Trametinib (3) Oncology RAS Warnings and Precautions   Trastuzumab (1) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies   Trastuzumab (2) Oncology ESR, PGR
(Hormone Receptor) Clinical Studies   Tretinoin Oncology PML-RARA Indications and Usage, Dosage and Administration, Warnings and Precautions, Patient Counseling Information   Triheptanoin Inborn Errors of Metabolism ACADVL, CPT2, HADHA, HADHB (Long-Chain Fatty Acid Oxidation Disorders) Indications and Usage, Clinical Studies   Tremelimumab-actl (1) Oncology ALK Indications and Usage, Clinical Studies   Tremelimumab-actl (2) Oncology EGFR Indications and Usage, Clinical Studies   Tremelimumab-actl (3) Oncology CD274
(PD-L1) Clinical Studies   Trimipramine Psychiatry CYP2D6 Precautions   Trofinetide Neurology     MECP2 Clinical Studies   Tucatinib (1) Oncology ERBB2
(HER2) Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Tucatinib (2) Oncology  Microsatellite Instability, Mismatch Repair     Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Studies   Tucatinib (3) Oncology     RAS     Clinical Studies   Umeclidinium Pulmonary CYP2D6 Clinical Pharmacology   Upadacitinib Rheumatology CYP2D6 Clinical Pharmacology   Ustekinumab Dermatology and Gastroenterology IL12A, IL12B, IL23A Warnings and Precautions   Valbenazine Neurology CYP2D6 Dosage and Administration, Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology   Valproic Acid (1) Neurology POLG Boxed Warning, Contraindications, Warnings and Precautions   Valproic Acid (2) Neurology Nonspecific
(Urea Cycle Disorders) Contraindications, Warnings and Precautions   Vemurafenib (1) Oncology BRAF Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies, Patient Counseling Information   Vemurafenib (2) Oncology RAS Warnings and Precautions, Adverse Reactions   Venetoclax (1) Oncology Chromosome 17p Clinical Studies   Venetoclax (2) Oncology Chromosome 11q Clinical Studies   Venetoclax (3) Oncology TP53 Clinical Studies   Venetoclax (4) Oncology IDH1 Clinical Studies   Venetoclax (5) Oncology IDH2 Clinical Studies   Venetoclax (6) Oncology IGHV Clinical Studies   Venetoclax (7) Oncology NPM1 Clinical Studies   Venetoclax (8) Oncology FLT3 Clinical Studies   Venlafaxine Psychiatry CYP2D6 Drug Interactions, Use in Specific Populations, Clinical Pharmacology   Viloxazine (1) Psychiatry CYP2D6 Clinical Pharmacology   Viloxazine (2) Psychiatry SLCO1B1 Clinical Pharmacology   Viltolarsen Neurology DMD Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies   Vincristine Oncology BCR-ABL1
(Philadelphia chromosome) Indications and Usage, Adverse Reactions, Clinical Studies   Voriconazole Infectious Diseases CYP2C19 Clinical Pharmacology   Vortioxetine Psychiatry CYP2D6 Dosage and Administration, Clinical Pharmacology   Voxelotor Hematology HBB Clinical Pharmacology, Clinical Studies   Vutrisiran Neurology TTR Adverse Reactions, Clinical Pharmacology, Clinical Studies   Warfarin (1) Hematology CYP2C9 Dosage and Administration, Drug Interactions, Clinical Pharmacology   Warfarin (2) Hematology VKORC1 Dosage and Administration, Clinical Pharmacology   Warfarin (3) Hematology PROS1 Warnings and Precautions   Warfarin (4) Hematology PROC Warnings and Precautions   Zanubrutinib (1) Oncology MYD88 Adverse Reactions, Clinical Studies   Zanubrutinib (2) Oncology     Chromosome 17p    Adverse Reactions, Clinical Studies   Zanubrutinib (3) Oncology     TP53     Clinical Studies   Zilucoplan Neurology ACHR Indications and Usage, Clinical Studies

Source